ArticleScientific reports2025
Predicting regional and temporal incidence of RSV and influenza hospitalizations in a birth cohort of young Australian children.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Respiratory Syncytial Virus-Related Hospitalizations Among Infants Receiving Nirsevimab.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Western Australia (WA) experiences multiple climatic zones, influencing the epidemiology of respiratory viruses. We aimed to estimate the true incidence of respiratory syncytial virus (RSV) and influenza hospitalizations across these different climatic regions using predictive modelling. We conducted a population-based cohort study using linked perinatal, hospitalization and microbiological data of children aged < 5 years, born in WA between 1 January 2010 and 31 December 2021. We used multivariable logistic regression to develop and validate predictive models for RSV and influenza hospitalizations in three climatic regions: southern temperate, northern tropical, and central desert. We compared laboratory-confirmed hospitalization rates with model-predicted rates and determined under-ascertainment fractions. Our cohort comprised 466,037 hospital admissions (257,960 children), with 33,106 tested for RSV (23.4% positive) and 33,511 for influenza (3.6% positive). True hospitalization rates for RSV and influenza were highest in the central desert and northern tropical regions. Among infants, RSV rates were 36.71 versus 20.00 per 1,000 child-years, and influenza rates were 444.59 versus 144.40 per 100,000 child-years in central desert compared to southern temperate areas. Routine laboratory testing significantly underestimated RSV (by 45-69%) and influenza (by 34-52%) hospitalizations. Unlike the southern and desert regions, the northern tropics lacked clear seasonal patterns. The study highlights high under-ascertainment of RSV and influenza hospitalizations from routine viral testing. The findings suggest immunization programs should consider viral circulation timing in different climatic regions. Prediction models demonstrated reliability in estimating RSV and influenza burden across varying climates, supporting localized decision-making beyond Australia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.